Redhill Biopharma
RDHL
#10795
Rank
โ‚ฌ4.68 M
Marketcap
0,77ย โ‚ฌ
Share price
8.34%
Change (1 day)
-55.92%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -705,09ย โ‚ฌ

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -613,13ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -2.190ย โ‚ฌ a decrease over its 2016 EPS that were of -1.927ย โ‚ฌ.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-705,09ย โ‚ฌ
2017-2.190ย โ‚ฌ13.64%
2016-1.927ย โ‚ฌ9.12%
2015-1.766ย โ‚ฌ68.01%
2014-1.051ย โ‚ฌ-25.93%
2013-1.419ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
2,24ย โ‚ฌ-100.37%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
3,12ย โ‚ฌ-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,40ย โ‚ฌ-100.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
1,20ย โ‚ฌ-100.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
1,07ย โ‚ฌ-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel